17th International Meeting of the European Society of Gynaecological Oncology (ESGO)
Webcasted Presentation

Search’n Build™

TARGETED THERAPY IN ENDOMETRIAL CANCER: STATUS AND PROMISING TARGETS

Prof. Helga B Salvesen
Prof. Helga B Salvesen
Canada  
Disclosure : The University of Bergen/Haukeland University Hospital/Dana Farber Cancer Institute/Harvard through BTO (Bergen Teknologioverføring AS): Some aspects relating to prognostic marker for endometrial cancer is subject on pending intellectual property rights (US 12/962,946) and some aspects are covered by license agreements.
[More] [Less]
15 slide(s) – 00:07:32 – English – 2011-09-12
Extra Features Available

VIDEO PODCAST
A A A  
Rate: Not useful Somewhat useful Mostly useful Useful Very useful

Please let us know how useful this content was for you
and feel free to write your comments below.